Drug
Rondaptivon pegol sodium clinical trials
Also written BT200.
Keep track of what changes. Save the rondaptivon pegol sodium studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Medical University of Vienna (2) · Band Therapeutics (1)
Studies
Open first, then newest update. How each study uses rondaptivon pegol sodium is read from its arms, and is right about nine times in ten.
Testing it · 3
- Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand DiseaseRecruitingPhase 2Medical University of ViennaNCT07273721Written as BT200
- A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal VolunteersCompletedPhase 1Band TherapeuticsNCT04103034Written as BT200
- BT200 in Hereditary Bleeding DisordersCompletedPhase 2Medical University of ViennaNCT04677803Written as BT200
Codes
What other systems call rondaptivon pegol sodium · ClinicalTrials.gg INT018581
- UNII (FDA) YD6HJ2PE4QRONDAPTIVON PEGOL SODIUMOne source FDA
- NCI Thesaurus C223456Rondaptivon Pegol SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | YD6HJ2PE4Q | RONDAPTIVON PEGOL SODIUM | One source FDA |
| NCI Thesaurus | C223456 | Rondaptivon Pegol Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.